Will Haskins

CEO & Co-Founder at Gryphon Bio

Dr. Haskins, in collaboration with Drs. Wang and Forsthuber, discovered unexpected waves of brain molecules in the blood as temporal biomarkers and therapeutic targets. He previously led teams for R&D of gene therapies, therapeutic antibody and antibody-drug conjugates from Research through Phase I/II/III clinical trials for small and large biotechnology companies. Dr. Haskins is well-respected for developing and applying out-of-the-box solutions to challenging problems as a consultant for numerous biotechnology companies.


Org chart


Teams


Offices

This person is not in any offices


Gryphon Bio

Gryphon Bio is a preclinical-stage therapeutic bioconjugate company created to harness our co-founders' discovery of novel therapeutic targets and temporal biomarkers in unexpected waves of brain molecules in the blood.


Industries

Employees

1-10

Links